Previous 10 | Next 10 |
home / stock / wllw:cc / wllw:cc news
WILLOW & SUANFARMA ANNOUNCE COMPLETED DEVELOPMENT AND MANUFACTURING PROCESS FOR CBG AND COMMITMENT TO THE PRODUCTION OF NEW MOLECULES IN A NATURAL WAY WILLOW & SUANFARMA ANNOUNCE COMPLETED DEVELOPMENT AND MANUFACTURING PROCESS FOR CBG AND COMMITMENT TO THE PRODUCTION OF NEW MOLE...
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIALS AND OPERATIONS AND FILING OF ITS 2022 AIF Canada NewsWire Reports Highest Quarterly and Annual Revenue in Company History with Significant Year-Over-Year Growth Expected for 2023 CALGARY, A...
WILLOW ANNOUNCES APPOINTMENT OF DR. JIM LALONDE TO BOARD OF DIRECTORS Canada NewsWire Dr. Lalonde has pioneered key advancements in enzyme engineering and biocatalysis that has revolutionized chemical production, protein engineering for food and nutrition, as well as drug disc...
WILLOW ANNOUNCES FOLLOW-ON ENGAGEMENT FOR NEXT PHASE OF PARTNERED PHARMACEUTICAL PROJECT Canada NewsWire Represents early progress against targeted milestones anticipated for 2023 to expand company growth CALGARY , AB and MOUNTAIN VIEW, Calif , ...
WILLOW PROVIDES CORPORATE UPDATES, BUSINESS OUTLOOK AND KEY TARGETED MILESTONES ANTICIPATED FOR 2023 TO EXPAND GROWTH Canada NewsWire CALGARY, AB AND MOUNTAIN VIEW, Calif. , Dec. 14, 2022 /CNW/ - Willow Biosciences Inc. (" Willow " or the " Co...
WILLOW FURTHER OPTIMIZES ITS BUSINESS TO FOCUS ON NEAR-TERM REVENUE GENERATION AND REDUCE CASH BURN Canada NewsWire CALGARY, AB and MOUNTAIN VIEW, Calif , Dec. 7, 2022 /CNW/ - Willow Biosciences Inc. (" Willow ") (TSX: WLLW) (OTCQB: CANSF), a leading...
KALSEC SIGNS MASTER SERVICES AGREEMENT WITH WILLOW BIOSCIENCES FOR THE DEVELOPMENT AND MANUFACTURE OF FUNCTIONAL FOOD INGREDIENTS USING PRECISION FERMENTATION Canada NewsWire KALAMAZOO, Mich. and CALGARY, AB and MOUNTAIN VIEW, Calif. , Nov. 8, 2022 ...
WILLOW BIOSCIENCES TO HOST INVESTOR PRESENTATION WEBCAST Canada NewsWire CALGARY, AB AND MOUNTAIN VIEW, Calif , Nov. 7, 2022 /CNW/ - Willow Biosciences Inc. (" Willow " or the " Company ") (TSX: WLLW) (OTCQB: CANSF), a leading b...
WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2022 RESULTS AND ANNOUNCES APPOINTMENT OF DR SEUFER-WASSERTHAL AS PRESIDENT AND CEO Canada NewsWire CALGARY, AB AND MOUNTAIN VIEW, CA , Nov. 3, 2022 /CNW/ - Willow Biosciences Inc. (" Willow " or the " Co...
WILLOW BIOSCIENCES ANNOUNCES NEW FUNCTIONAL INGREDIENT ASTAXANTHIN ADDED TO PRODUCT PORTFOLIO Canada NewsWire CALGARY, AB and MOUNTAIN VIEW, Calif. , Oct. 12, 2022 /CNW/ - Willow Biosciences Inc. (" Willow " or the " Company ") (TSX:...
News, Short Squeeze, Breakout and More Instantly...
Willow Biosciences Inc. Company Name:
WLLW:CC Stock Symbol:
TSXC Market:
Willow Biosciences Inc. Website:
WILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF UNITS Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ./ CALGARY, AB , July 18, 2024 /CNW/ - Willow Biosciences Inc. ...
WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM Canada NewsWire Company announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients Company anticipates ...
--News Direct-- Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share the company's plans to raise approximately $3 million. This capital will be used to support Willow Bioscience's recent partnership announcement with Laurus Labs. Dr. Savile explained tha...